当前位置: X-MOL 学术CNS Neurosci. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Human urinary kallidinogenase in acute ischemic stroke: A single-arm, multicenter, phase IV study (RESK study)
CNS Neuroscience & Therapeutics ( IF 5.5 ) Pub Date : 2021-09-12 , DOI: 10.1111/cns.13724
Jun Ni 1 , Ming Yao 1 , Li-Hua Wang 2 , Ming Yu 3 , Run-Hui Li 4 , Li-Hong Zhao 5 , Jia-Chun Wang 6 , Yin-Zhou Wang 7 , Xin Wang 8 , Hai-Qing Song 9 , Ben-Yan Luo 10 , Jia-Wei Wang 11 , Yi-Ning Huang 12 , Li-Ying Cui 1 ,
Affiliation  

Human urinary kallidinogenase (HUK) has shown favorable efficacies in acute ischemic stroke (AIS) treatment. We sought confirmation of the safety and efficacy of HUK for AIS in a large population.

中文翻译:

急性缺血性卒中中的人尿激肽原酶:一项单臂、多中心、IV 期研究(RESK 研究)

人尿激肽原酶 (HUK) 在急性缺血性卒中 (AIS) 治疗中显示出良好的疗效。我们寻求在大量人群中确认 HUK 对 AIS 的安全性和有效性。
更新日期:2021-09-12
down
wechat
bug